This issue of Medical Clinics of North America, edited by Dr. Irl Hirsch, is devoted to Diabetes Management. Articles in this issue include: Diabetes Classification Update; Internet Diabetes Management: An Effective, Efficient, and Cost Effective Approach; Monitoring Glycemia in Diabetes; Glycemic Targets: What is the Evidence?; Lifestyle Modification in Diabetes; Metformin, Sufonlyureas, Acarbose, Thiazolidnediones, Bromocriptine, and Colesevalam; Incretins; SGLT-2 inhibitors; Insulin therapy in Type 1 Diabetes; Insulin Therapy in Type 2 Diabetes; Non-Glycemic Targets for Patients with Diabetes; Screening and Treatment for the Primary Care Provider of Common Diabetes Complications; and Polycystic Ovarian Syndrome.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. CME Accreditation Page - p. 5 6. Forthcoming Issues - p. 6 7. Contributors - p. 7 8. Foreword: Diabetes Management - p. 10 9. Preface: Diabetes Management - p. 11 10. Erratum - p. 12 11. Update on Diabetes Classification - p. 13 12. Internet Blood Glucose Monitoring Systems Provide Lasting Glycemic Benefit in Type 1 and 2 Diabetes - p. 23 13. Monitoring Glycemia in Diabetes - p. 31 14. Glycemic Targets - p. 37 15. Lifestyle Intervention - p. 47 16. Oral Antihyperglycemic Treatment Options for Type 2 Diabetes Mellitus - p. 56 17. Incretin-Based Therapies - p. 68 18. Sodium Glucose Cotransporter 2 Inhibitors - p. 79 19. Insulin Therapy in Type 1 Diabetes - p. 87 20. Insulin Tactics in Type 2 Diabetes - p. 94 21. Nonglycemic Targets in Diabetes - p. 108 22. Screening and Treatment by the Primary Care Provider of Common Diabetes Complications - p. 116 23. Polycystic Ovarian Syndrome - p. 126 24. Index - p. 134
This issue of Medical Clinics of North America, edited by Dr. Irl Hirsch, is devoted to Diabetes Management. Articles in this issue include: Diabetes Classification Update; Internet Diabetes Management: An Effective, Efficient, and Cost Effective Approach; Monitoring Glycemia in Diabetes; Glycemic Targets: What is the Evidence?; Lifestyle Modification in Diabetes; Metformin, Sufonlyureas, Acarbose, Thiazolidnediones, Bromocriptine, and Colesevalam; Incretins; SGLT-2 inhibitors; Insulin therapy in Type 1 Diabetes; Insulin Therapy in Type 2 Diabetes; Non-Glycemic Targets for Patients with Diabetes; Screening and Treatment for the Primary Care Provider of Common Diabetes Complications; and Polycystic Ovarian Syndrome.
1. Cover image - p. 1 2. Title page - p. 2 3. Table of Contents - p. 3 4. Copyright - p. 4 5. CME Accreditation Page - p. 5 6. Forthcoming Issues - p. 6 7. Contributors - p. 7 8. Foreword: Diabetes Management - p. 10 9. Preface: Diabetes Management - p. 11 10. Erratum - p. 12 11. Update on Diabetes Classification - p. 13 12. Internet Blood Glucose Monitoring Systems Provide Lasting Glycemic Benefit in Type 1 and 2 Diabetes - p. 23 13. Monitoring Glycemia in Diabetes - p. 31 14. Glycemic Targets - p. 37 15. Lifestyle Intervention - p. 47 16. Oral Antihyperglycemic Treatment Options for Type 2 Diabetes Mellitus - p. 56 17. Incretin-Based Therapies - p. 68 18. Sodium Glucose Cotransporter 2 Inhibitors - p. 79 19. Insulin Therapy in Type 1 Diabetes - p. 87 20. Insulin Tactics in Type 2 Diabetes - p. 94 21. Nonglycemic Targets in Diabetes - p. 108 22. Screening and Treatment by the Primary Care Provider of Common Diabetes Complications - p. 116 23. Polycystic Ovarian Syndrome - p. 126 24. Index - p. 134
